Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| 1 |
Apple
AAPL
|
+$790M |
| 2 |
Microsoft
MSFT
|
+$769M |
| 3 |
Coca-Cola
KO
|
+$720M |
| 4 |
NVIDIA
NVDA
|
+$700M |
| 5 |
Amgen
AMGN
|
+$697M |
Top Sells
| 1 |
Vanguard Real Estate ETF
VNQ
|
+$251M |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$244M |
| 3 |
Oracle
ORCL
|
+$214M |
| 4 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$176M |
| 5 |
MRO
Marathon Oil Corporation
MRO
|
+$140M |
Sector Composition
| 1 | Technology | 23.63% |
| 2 | Financials | 12.75% |
| 3 | Consumer Discretionary | 9.87% |
| 4 | Healthcare | 9.85% |
| 5 | Industrials | 8.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Teekay
TK
$721M
| $2.59M | ﹤0.01% |
374,291
-231,350
| -38% | -$1.6M |
|
2602
argenx
ARGX
$46.7B
| $2.59M | ﹤0.01% |
4,214
+755
| +22% | +$464K |
|
2603
Monte Rosa Therapeutics
GLUE
$296M
| $2.57M | ﹤0.01% |
370,472
+23,974
| +7% | +$166K |
|
2604
Cerus
CERS
$226M
| $2.57M | ﹤0.01% |
1,666,366
-88,174
| -5% | -$136K |
|
2605
Haleon
HLN
$44B
| $2.54M | ﹤0.01% |
265,744
+62,161
| +31% | +$593K |
|
2606
Allogene Therapeutics
ALLO
$246M
| $2.53M | ﹤0.01% |
1,188,838
+9,990
| +0.8% | +$21.3K |
|
|
SAGE
2607
DELISTED
Sage Therapeutics
SAGE
| $2.51M | ﹤0.01% |
462,309
+10,116
| +2% | +$54.9K |
|
2608
Honda
HMC
$44.4B
| $2.51M | ﹤0.01% |
87,924
-10,862
| -11% | -$310K |
|
2609
GoodRx Holdings
GDRX
$1.43B
| $2.5M | ﹤0.01% |
538,588
+58,465
| +12% | +$272K |
|
2610
Cooper-Standard Automotive
CPS
$685M
| $2.5M | ﹤0.01% |
184,664
-133,528
| -42% | -$1.81M |
|
|
CBLL
2611
CeriBell, Inc. Common Stock
CBLL
$419M
| $2.5M | ﹤0.01% |
+96,582
| New | +$2.5M |
|
2612
Fulcrum Therapeutics
FULC
$378M
| $2.47M | ﹤0.01% |
526,045
-43,140
| -8% | -$203K |
|
2613
Hamilton Insurance Group
HG
$2.34B
| $2.44M | ﹤0.01% |
128,136
+17,342
| +16% | +$330K |
|
2614
Groupon
GRPN
$916M
| $2.44M | ﹤0.01% |
200,436
+1,449
| +0.7% | +$17.6K |
|
2615
Lennar Class B
LEN.B
$33.8B
| $2.42M | ﹤0.01% |
+19,304
| New | +$2.42M |
|
2616
Ranpak Holdings
PACK
$407M
| $2.42M | ﹤0.01% |
352,346
+7,796
| +2% | +$53.6K |
|
|
RVNC
2617
DELISTED
Revance Therapeutics, Inc.
RVNC
| $2.42M | ﹤0.01% |
797,299
+6,462
| +0.8% | +$19.6K |
|
2618
Kiniksa Pharmaceuticals
KNSA
$2.68B
| $2.41M | ﹤0.01% |
122,019
+32,393
| +36% | +$641K |
|
2619
The Honest Company
HNST
$422M
| $2.41M | ﹤0.01% |
348,133
+122,566
| +54% | +$849K |
|
2620
Microvision
MVIS
$334M
| $2.4M | ﹤0.01% |
1,832,066
+134,479
| +8% | +$176K |
|
2621
SmartRent
SMRT
$269M
| $2.39M | ﹤0.01% |
1,367,677
-147,447
| -10% | -$258K |
|
2622
Tyra Biosciences
TYRA
$635M
| $2.37M | ﹤0.01% |
170,600
-3,137
| -2% | -$43.6K |
|
2623
Latham Group
SWIM
$911M
| $2.37M | ﹤0.01% |
340,603
+7,397
| +2% | +$51.5K |
|
2624
Woodside Energy
WDS
$31.4B
| $2.35M | ﹤0.01% |
150,770
+10,110
| +7% | +$158K |
|
2625
MBIA
MBI
$374M
| $2.35M | ﹤0.01% |
363,576
-20,906
| -5% | -$135K |
|